Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging
about
Dysregulation of iron and copper homeostasis in nonalcoholic fatty liverCardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An updateAn evidence-based update on the pharmacological activities and possible molecular targets of Lycium barbarum polysaccharidesAge as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis.A new noninvasive technique for estimating hepatic triglyceride: will liver biopsy become redundant in diagnosing non-alcoholic fatty liver disease?Insulin receptor Thr1160 phosphorylation mediates lipid-induced hepatic insulin resistance.Republished: Non-alcoholic fatty liver disease: a practical approach to treatment.Nonalcoholic Steatohepatitis: A Search for Factual Animal Models.The promise of metabolic phenotyping in gastroenterology and hepatology.Efficacy of poly-unsaturated fatty acid therapy on patients with nonalcoholic steatohepatitis.Hyperreactivity of Blood Leukocytes in Patients with NAFLD to Ex Vivo Lipopolysaccharide Treatment Is Modulated by Metformin and Phosphatidylcholine but Not by Alpha Ketoglutarate.Awareness of nonalcoholic steatohepatitis and associated practice patterns of primary care physicians and specialists.Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease researchDevelopment of Serum Marker Models to Increase Diagnostic Accuracy of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: The New LINKI Algorithm Compared with Established Algorithms.Body Mass Index and Risk of Nonalcoholic Fatty Liver Disease: Two Electronic Health Record Prospective Studies.Association of the Nonalcoholic Hepatic Steatosis and Its Degrees With the Values of Liver Enzymes and Homeostasis Model Assessment-Insulin Resistance Index.Absorption, Distribution, Metabolism, and Excretion of [(14)C]-Volixibat in Healthy Men: Phase 1 Open-Label Study.Nonalcoholic fatty liver disease - current status and future directions.Routine Liver Biopsy During Bariatric Surgery: an Analysis of Evidence Base.Metabolic syndrome and non-alcoholic fatty liver disease after liver or kidney transplantation.Visual Liver Score to Stratify Non-Alcoholic Steatohepatitis Risk and Determine Selective Intraoperative Liver Biopsy in Obesity.Acetyl-coenzyme A carboxylase inhibition reduces de novo lipogenesis in overweight male subjects: A randomized, double-blind, crossover study.Performance of transient elastography and serum fibrosis biomarkers for non-invasive evaluation of recurrent fibrosis after liver transplantation: A meta-analysis.Non-alcoholic fatty liver disease: a practical approach to treatment.Highlights from this issue.Care standards for non-alcoholic fatty liver disease in the United Kingdom 2016: a cross-sectional survey.Influence of Roux-en-Y Gastric Bypass on the Hepatocellular Function and Bile Flow of Obese Patients Assessed by Scintigraphy with DISIDA.Investigation of Clinical and Pathological Relationships between Adult- and Pediatric-type NASH in Korean Children.Editorial: progress towards a simple tool for screening for hepatic steatosis in the general population.Editorial: further evidence for the use of advanced magnetic resonance imaging techniques to monitor NAFLD.Morphofunctional Changes After Sleeve Gastrectomy and Very Low Calorie Diet in an Animal Model of Non-Alcoholic Fatty Liver Disease.Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels.Supervised learning reveals circulating biomarker levels diagnostic of hepatocellular carcinoma in a clinically relevant model of non-alcoholic steatohepatitis; An OAD to NASH.Multi-scale, whole-system models of liver metabolic adaptation to fat and sugar in non-alcoholic fatty liver diseaseThe role of anthropometric indices in the prediction of non-alcoholic fatty liver disease in the PERSIAN Guilan Cohort study (PGCS)The Role of Long Non-Coding RNAs (lncRNAs) in the Development and Progression of Fibrosis Associated with Nonalcoholic Fatty Liver Disease (NAFLD)Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunctionAcoustic radiation force impulse accuracy and the impact of hepatic steatosis on liver fibrosis staging
P2860
Q26996539-4BD8415E-DE40-4385-839A-872122CD3D89Q26997059-6FC16322-AD0C-4D9F-9B81-80E57A30F505Q28385065-19CEC52D-45AF-44E3-A1C9-3729283EDC26Q33639969-20EF6EC4-C79B-4986-9842-7F20F78038CFQ34103558-88E78EFE-8D7D-4F9A-9537-18167047B136Q34543004-D7881622-ADDB-4639-9E8F-EA5CD597C950Q35135556-E7A1CF60-C9E9-4BDC-AE7D-31EA06CC5D52Q35612535-80EF4046-2E18-4988-958D-32A28607F357Q35701279-A520FF36-9FC8-4D17-9DAF-AA4221EC40D3Q35716357-FE4167A3-0FDC-4BCB-8096-89E5CDF8AC35Q35858593-C24F8E51-431E-4DAA-8F7D-59DAD860BEAAQ35954671-B83D8A09-3728-4F91-9DBA-80D41C372311Q36129673-8DF782DC-62BA-4917-83EF-A4A381B0F641Q36218142-24333393-70A3-4A11-8F9F-E774B34B18B7Q36716045-683229BD-5D84-4B00-87EF-9A9A82DC2E0BQ37311490-D3C18F0B-8FE4-4888-98AC-5920CA3FB37CQ38374046-0F46E154-3D9C-4A5B-A74C-9222CEAB28D7Q38592767-BB8B3C58-4308-421B-BE95-2B5C24CCC35CQ38597198-68AE67D6-F846-41CB-99F6-F1683218994AQ38682089-78112A19-B553-4831-9293-875A117D3419Q40095053-CF9968F2-A73E-4EBB-8700-01AA7D3C8EAFQ41837751-25BF4D5A-F1B1-4096-B24D-74B211310438Q42365178-EEB8FD1F-2267-4CB4-BC3F-2FB5FBB7EE8BQ42913256-143818D2-F2DC-4635-B534-FEC95939F4A2Q45744966-CB6B593B-C27B-43D8-9E06-EB864EAC190EQ47234787-A7A50A3B-6266-4977-904F-22C493DD355DQ47660505-78BE049E-B5BA-4E06-A934-51BB5FA8B5E1Q48210705-883CB33A-D5E6-4B80-8087-357AEDBDBF52Q48291741-BFA768CF-4465-4071-902F-483996E442E5Q48334549-68EAC5A4-986B-44DE-B7A4-68171E229489Q50202622-14DA974D-1FBF-4E5B-8289-C174DEECA0ACQ53659147-E55BC71C-FFD7-4D71-AFA3-D28FEC0345FFQ55498607-C5C6C275-960E-483B-BB29-8CA5DE298B0AQ58417407-B0767263-B604-4C49-9B69-0F9A97482BDDQ58570672-1D5E7AF0-B18D-4EF5-BED2-6B0CD44A3873Q58726261-190DA5BF-89A5-4C75-A6A6-4B85CAA3F2BEQ58796002-948BF572-D988-4688-9B14-E44B27E9F807Q59286707-1D1BD02E-2BAD-4EA7-A025-DD0F80B5A9FE
P2860
Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging
@ast
Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging
@en
Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging
@nl
type
label
Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging
@ast
Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging
@en
Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging
@nl
prefLabel
Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging
@ast
Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging
@en
Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging
@nl
P2860
P1476
Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging
@en
P2093
Jessica K Dyson
P2860
P304
P356
10.1136/FLGASTRO-2013-100403
P577
2013-12-24T00:00:00Z